SUTIB 50 CAPSULE contains Sunitinib which belongs to the group of medicines called Protein Kinase Inhibitors. It is used in the management of gastrointestinal stromal tumor (GIST) (a type of cancer of the stomach and bowel) where another anticancer medicine (imatinib) no longer works or you cannot take it and metastatic renal cell carcinoma (MRCC) (type of kidney cancer that has spread to other parts of the body).
SUTIB 50 CAPSULE is also used to manage pancreatic neuroendocrine tumors (pNET) (tumors of the hormone-producing cells in the pancreas) that have progressed or cannot be removed with surgery. Your doctor might ask you to take blood tests, check your blood pressure and take your ECG during management with SUTIB 50 CAPSULE and as clinically indicated.
Before taking SUTIB 50 CAPSULE, inform your doctor if you have heart, kidney, liver, blood, thyroid or pancreatic problems, seizures and diabetes or if you recently had or are going to undergo any surgery.
Ask your doctor before taking SUTIB 50 CAPSULE during pregnancy. You should not breastfeed while taking SUTIB 50 CAPSULE so, consult your doctor before taking it. It is not known if SUTIB 50 CAPSULE is safe and effective in children and it should be used with caution in elderly patients (65 years and above).
The most common side effects of taking SUTIB 50 CAPSULE are rashes, itching, muscle cramps, bone pain weakness, tiredness, diarrhea, nausea, vomiting, stomach pain, etc. Contact your doctor if any of the symptoms worsen or persists.
No content available
